2016 Data Sleep Treatment 
Cannabis Law Report
MAY 10, 2022
Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes.
Project CBD
JANUARY 24, 2019
In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” The improvements include decreased aggression and agitation, fewer seizures, and better sleep, appetite and ability to concentrate. Cannabis and ADHD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 10, 2022
First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Medicinal cannabis as a last resort.
Veriheal
JANUARY 26, 2023
A 2016 experiment conducted by scientists from Harvard Medical School, Tufts University, and McLean Hospital explored the impact of marijuana on both mood and cognitive function in those diagnosed with this mental health condition, making it the first such study ever undertaken in this area. The post Is Cannabis Good for Bipolar Disorder?
Healer
MARCH 26, 2021
Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.
CannaMD
JUNE 18, 2020
Closer examination of the data revealed a number of important traits that influenced outcomes. In a 2016 assessment of the California and Minnesota studies, the authors noted: After adjustment for other substance use, these declines [in IQ] were substantially attenuated and no longer statistically significant. Find Out if You Qualify.
Freedom Leaf
OCTOBER 15, 2018
This move reinforced a federal ruling on April 16 that affirmed the December 2016 DEA decision to create a new Schedule I code for cannabis extracts, including CBD extracts. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9
Expert insights. Personalized for you.
52 
Let's personalize your content